How Artificial Intelligence Is Disrupting Medicine
Acclaimed tech investment expert Paul Mampilly recently shed light on the next generation of America’s precision medicine mega trend. And he considers it to be one of the biggest innovations of the 21st century.
Paul refers to this new tech field as “living technology.”
It has attracted legendary tech investors like Bill Gates, Peter Thiel and Eric Schmidt.
The Food and Drug Administration says it has the potential to “transform medicine.”
And this technology is expected to grow 4,300% by 2025 while saving countless lives.
This marriage of tech and medicine stands to conquer leukemia, lung cancer, blindness, multiple sclerosis and more.
Those who’ve followed Paul’s various tech insights like the breakthroughs being made in “living technology” love the kind of win-win opportunities they’ve seen.
Like Stan K., who stated:
I was so surprised yesterday with a 188% gain on your recent recommendation. But you know what was even more rewarding? That they were successful with 100% of muscular dystrophy patients in clinical trial. It’s a 100% win for all. Thanks!
And Jessica E., who told Paul:
I truly believe your recommendations touch on more than just making money. I’m up a whopping 175% on a company in the business of helping people stricken with illness. Thank you for backing stocks that make such a difference in people’s lives.
So, what is “living technology”?
Living tech is already disrupting the stagnant pharma market.
Recent developments in artificial intelligence (AI) by one company have finally given the pharmaceutical industry the tremendous AI computing power it needs.
Without getting too technical, this allows drug manufacturing times to speed up significantly.
That means drugs get tested faster, get to market faster and save lives faster.
This is truly a win for science, for medicine and for humanity.
These kinds of feel-good investment opportunities are among Paul’s favorite to recommend.
You can take advantage of biotech breakthroughs like living tech by investing in the Alps Medical Breakthroughs ETF (NYSE: SBIO).
Or if you prefer to see details on the specific company he believes is leading the living tech revolution, you can see Paul’s new presentation on his top living tech pick here.